← Leaderboards
David Patrick
Veterans Health Administration
$471,588
Attributed
$471,588
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $158.4K · FY2009–25$200K$150K$100K$50K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$471,588 · 3
VA$0 · 1
By mechanism
K08$316,872 · 1
F30$84,766 · 1
F32$69,950 · 1
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Veterans Health Administration
Same institution · by research overlap
- Jack J Hawiger$18,218,108
- Deirdre A Quinn$0
- Vineet Agrawal$443,872
- Eric R Tkaczyk$1,587,602
- Tracy Minan Frech$1,410,418
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelPreventResponseInsightAffectNovel TherapeuticsLysineOrganImmune ActivationFlow CytometryComplexMonocyteAttenuatedMulticatalytic Endopeptidase ComplexInflammationCardiovascular DiseasesCareerDesignAdductCharacteristicsAntigen-Presenting CellsHypertensionAutoantigensDendritic Cells
Grant awards (10)
A Role of Isolevuglandins in Essential Hypertension and Systemic Lupus Erythematosus$0
IK2 · FY2025 · VA · contact PI
A Role of Isolevuglandins in Essential Hypertension and Systemic Lupus Erythematosus$0
IK2 · FY2024 · VA · contact PI
A Role of Isolevuglandins in Essential Hypertension and Systemic Lupus Erythematosus$0
IK2 · FY2023 · VA · contact PI
A Role of Isolevuglandins in Essential Hypertension and Systemic Lupus Erythematosus$0
IK2 · FY2022 · VA · contact PI
A Role of Isolevuglandin Adducts in Essential Hypertension and Systemic Lupus Erythematosus$158,436
K08 · FY2021 · HL · contact PI
A Role of Isolevuglandin Adducts in Essential Hypertension and Systemic Lupus Erythematosus$158,436
K08 · FY2020 · HL · contact PI
Isolevuglandin peptide modification and proteasomal processing is responsible for autoimmune mediated hypertension$69,950
F32 · FY2019 · HL · contact PI
Regulation of cardiac hypertrophy by microRNA-21$28,062
F30 · FY2012 · HL · contact PI
Regulation of cardiac hypertrophy by microRNA-21$28,708
F30 · FY2011 · HL · contact PI
Regulation of cardiac hypertrophy by microRNA-21$27,996
F30 · FY2009 · HL · contact PI